| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |